Search Results 331-340 of 18828 for crohns disease

  1. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this extension study is to evaluate the safety and effectiveness of ozanimod in subjects with moderately to severely active Crohn's Disease.

  2. Pouchitis - Symptoms and causes - Mayo Clinic

    Having inflammatory bowel disease, also called IBD. Pouchitis happens more often in people who have underlying IBD , such as ulcerative colitis. Using ...

  3. Mucus in stool: A concern? - Mayo Clinic

    Bloody mucus in stool or mucus along with belly pain may signal a more serious condition, such as Crohn's disease, ulcerative colitis and even cancer. ... A Book: ...

  4. Early Mayo Clinic research finds hope in stem cell therapy for perianal fistulas in patients with Crohn's disease

    As many as 26% of people with Crohn's disease will develop perianal fistulas. Most often, it starts with an infection within the anal gland and often progresses ...

  5. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.

  6. Francis A. Farraye, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    He co-edited the text, Curbside Consultation in Inflammatory Bowel Disease (now in its 3rd edition) and Gastrointestinal Emergencies. His books for patients ...

  7. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease. Participation eligibility.

  8. Study to Assess Limited Magnetic Resonance Imaging in the Surveillance of Crohn's Disease - Mayo Clinic

    Study to Assess Limited Magnetic Resonance Imaging in the Surveillance of Crohn's Disease ... Participant eligibility includes age, gender, type and stage of ...

  9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    To determine the efficacy and safety of multiple doses of ABT-494 in subjects with moderately to severely active Crohn's Disease with a history of inadequate ...

  10. Small intestinal bacterial overgrowth (SIBO) - Symptoms & causes - Mayo Clinic

    ... problems and some diseases. Sometimes surgery ... Certain medical conditions, including Crohn's disease, radiation enteritis, scleroderma, celiac disease ...